Chargement...

Robocath successfully completes first robotic coronary angioplasties in Germany with R-One™

21 January 2020

Rouen, France, January 21, 2020 – Robocath, a company that designs, develops and commercializes cardiovascular robotic systems for the treatment of vascular diseases, today announces it has successfully completed its first robotic coronary angioplasties with R-One™ in Germany. The Percutaneous Coronary Interventions (PCI) were performed by Prof. Michael Haude, a recognized and highly experienced interventional cardiologist at Rheinland Klinikum Neuss Lukaskrankenhaus, and his team.  

Prof. Michael Haude, Director of Medical Clinic I at Rheinland Klinikum Neuss Lukaskrankenhaus, said, “I’m proud…

Learn more

Robocath successfully completes first robotic coronary angioplasties in Africa

16 December 2019

Rouen, France, December 16, 2019 – Robocath, a company that designs, develops and commercializes cardiovascular robotic systems for the treatment of vascular diseases, today announces it has successfully completed six robotic coronary angioplasties with R-One™, a first for the continent of Africa. These Percutaneous Coronary Interventions (PCI) were performed by Dr Faizel Lorgat, an interventional cardiologist at the Netcare Christiaan Barnard Memorial Hospital, Cape Town, as part of a distribution agreement with Vertice MedTechGroup. These procedures will lead to the…

Learn more
29 January 2020

High Tech Cardio 2020 - Marseille (France)

#Robocath
Subscribe to our newsletter